Detalhe da pesquisa
1.
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions.
CA Cancer J Clin
; 73(6): 620-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329269
2.
Immune checkpoint inhibitors as adjuvant therapy in patients with completely resected nonsmall cell lung cancer.
Curr Opin Oncol
; 36(1): 24-28, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865822
3.
Immunotherapy combinations in advanced nonsmall cell lung cancer.
Curr Opin Oncol
; 33(1): 73-79, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33186185
4.
Chemotherapy remains a cornerstone in the treatment of nonsmall cell lung cancer.
Curr Opin Oncol
; 32(1): 63-67, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31599771
5.
Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer.
Curr Opin Oncol
; 32(1): 68-77, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31714259
6.
Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.
Oncologist
; 24(1): e30-e37, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181313
7.
Biomarkers for immune checkpoint inhibitors in advanced nonsmall cell lung cancer.
Curr Opin Oncol
; 31(1): 24-28, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418192
8.
Editorial: Recent diagnostic and therapeutic advances in lung cancer.
Curr Opin Oncol
; 36(1): 22-23, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085870
9.
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer.
Haematologica
; 103(9): 1549-1556, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29794142
10.
Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice.
Cancer Metastasis Rev
; 35(1): 141-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970967
11.
Editorial: Lung cancer: continuous progress in diagnosis and treatment.
Curr Opin Oncol
; 34(1): 29-31, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710885
12.
Trimodality therapy for Pancoast tumors: T4 is not a contraindication to radical surgery.
J Surg Oncol
; 116(2): 227-235, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28407246
13.
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Oncologist
; 21(10): 1183-1190, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401890
14.
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
N Engl J Med
; 368(12): 1101-10, 2013 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514287
15.
Third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer.
Curr Opin Oncol
; 28(2): 115-21, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26720671
16.
Editorial: Individualizing treatment of nonsmall cell lung cancer.
Curr Opin Oncol
; 32(1): 35-36, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31652144
17.
Epidermal growth factor receptor-directed monoclonal antibodies in nonsmall cell lung cancer: an update.
Curr Opin Oncol
; 27(2): 87-93, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636162
18.
What is the best strategy for targeting EGF receptors in non-small-cell lung cancer?
Future Oncol
; 11(1): 153-67, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25572790
19.
Novel drugs against non-small-cell lung cancer.
Curr Opin Oncol
; 26(2): 145-51, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24406751
20.
EGFR monoclonal antibody biomarkers in advanced NSCLC: from translational research to clinical implementation.
Lancet Oncol
; 19(1): 10-12, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29169876